(Q44145621)

English

Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection

scientific article published in June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

author name string

Domingo P

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Torres OH

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Ris J

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Vazquez G

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

605-609

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. Groupe d'Epidémiologie clinique du SIDA en aquitaine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Herpes Zoster and Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Herpes zoster, immunological deterioration and disease progression in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

RISK OF AIDS AFTER HERPES ZOSTER

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Immune recovery inflammatory folliculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Herpes zoster and postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Postherpetic neuralgia. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus. Italian HIV Seroconversion Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

CD8+ lymphocyte responses to antiretroviral therapy of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900703-3

7 January 2021

Identifiers

10.1016/S0002-9343(01)00703-3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44145621&oldid=2107112559"